Sanjay Popat

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 47

Top Venues

British journal of cancer

Targeted oncology

Journal of comparative effectiveness research

Journal of clinical medicine

Institute of Cancer Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research

United Kingdom

Professor of Thoracic Oncology :: Thoracic Oncology

Imperial College London

United Kingdom

Reader :: National Heart & Lung Institute

Royal Marsden NHS Foundation Trust

United Kingdom

Consultant Medical Oncologist :: Lung Unit

Publications

Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research 13 (3) (2024)
Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research 13 (3) (2024)
Aju Mathew, Sissmol Davis, Jeffrey Mathew Boby, Anu R I, Moushumi Suryavanshi, Shaheenah S Dawood, Pankaj Kumar Panda, Shona Milon Nag, Arunangshu Das, Nitesh Rohatgi, Sanjay Popat, Riyaz N H Shah, Cherian Thampy, Aparna Raj Parikh, Siddhartha Yadav, Prashant Mehta, Randeep Singh, Deborah A Mukherji, Ramila Shilpakar, Sujith Kumar Mullapally, Bhawna Sirohi
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India. JCO global oncology 10 (2024)
Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research 13 (3) (2024)
Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research 13 (3) (2024)
Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research (2024)
Thanika Ketpueak, Daniel Shao-Weng Tan, Sanjay Popat
Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: End of the Road or the First Chapter? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram V Ramagopalan, Alind Gupta, Grace G Hsu, Paul Arora, Vivek Subbiah
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of comparative effectiveness research 13 (3) (2024)
Aju Mathew, Sissmol Davis, Jeffrey Mathew Boby, Anu R I, Moushumi Suryavanshi, Shaheenah S Dawood, Pankaj Kumar Panda, Shona Milon Nag, Arunangshu Das, Nitesh Rohatgi, Sanjay Popat, Riyaz N H Shah, Cherian Thampy, Aparna Raj Parikh, Siddhartha Yadav, Prashant Mehta, Randeep Singh, Deborah A Mukherji, Ramila Shilpakar, Sujith Kumar Mullapally, Bhawna Sirohi
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India. JCO global oncology 10 (2024)
Aju Mathew, Sissmol Davis, Jeffrey Mathew Boby, Anu R I, Moushumi Suryavanshi, Shaheenah S Dawood, Pankaj Kumar Panda, Shona Milon Nag, Arunangshu Das, Nitesh Rohatgi, Sanjay Popat, Riyaz N H Shah, Cherian Thampy, Aparna Raj Parikh, Siddhartha Yadav, Prashant Mehta, Randeep Singh, Deborah A Mukherji, Ramila Shilpakar, Sujith Kumar Mullapally, Bhawna Sirohi
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India. JCO global oncology 10 (2024)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology 18 (1) (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology 18 (1) (2023)
Kevin W Ng, Jesse Boumelha, Katey S S Enfield, Jorge Almagro, Hongui Cha, Oriol Pich, Takahiro Karasaki, David A Moore, Roberto Salgado, Monica Sivakumar, George R Young, Miriam Molina-Arcas, Sophie de Carné Trécesson, Panayiotis Anastasiou, Annika Fendler, Lewis Au, Scott T C Shepherd, Carlos Martínez-Ruiz, Clare Puttick, James R M Black, Thomas B K Watkins, Hyemin Kim, Seohee Shim, Nikhil Faulkner, Jan Attig, Selvaraju Veeriah, Neil Magno, Sophia Ward, Alexander M Frankell, Maise Al Bakir, Emilia L Lim, Mark S Hill, Gareth A Wilson, Daniel E Cook, Nicolai Juul Birkbak, Axel Behrens, Nadia Yousaf, Sanjay Popat, Allan Hackshaw, null null, null null, Crispin T Hiley, Kevin Litchfield, Nicholas McGranahan, Mariam Jamal-Hanjani, James Larkin, Se-Hoon Lee, Samra Turajlic, Charles Swanton, Julian Downward, George Kassiotis
Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology (2023)
Matthew G Krebs, Sanjay Popat
RETaliation - tackling rare resistance alterations to osimertinib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer 128 (2) (2023)
Preetha Aravind, Sanjay Popat, Tara D Barwick, Neil Soneji, Mark Lythgoe, Katherina B Sreter, Jingky P Lozano-Kuehne, Mattias Bergqvist, Neva Patel, Eric O Aboagye, Laura M Kenny
A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18 F-Fluorothymidine "Flare" on Positron Emission Tomography. Cancers 15 (14) (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology 18 (1) (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer 128 (2) (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer 128 (2) (2023)
Petros Christopoulos, Nicolas Girard, Claudia Proto, Marta Soares, Pilar Garrido Lopez, Anthonie J van der Wekken, Sanjay Popat, Joris Diels, Claudio A Schioppa, Jan Sermon, Nora Rahhali, Corinna Pick-Lauer, Agnieszka Adamczyk, James Penton, Marie Wislez
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations. Cancers 15 (22) (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer 128 (2) (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlings, Stephan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer (2023)
Sanjay Popat, Myung-Ju Ahn, Simon Ekman, Natasha B Leighl, Suresh S Ramalingam, Thanyanan Reungwetwattana, Shankar Siva, Masahiro Tsuboi, Yi-Long Wu, James Chih-Hsin Yang
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targeted oncology 18 (1) (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer (2023)
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary M Middleton, Peter Johnson, Charles Swanton, null null
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. British journal of cancer (2023)
Elizabeth A Coker, Adam Stewart, Bugra Ozer, Anna R Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary Er O'Brien, Florence Raynaud, Johann S de Bono, Bissan Al-Lazikani, Udai Banerji
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes. Molecular cancer therapeutics 21 (6) (2022)
Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Stephen Kay, Laura J Walton, Junwu Shen, Sanjay Popat, D Ross Camidge
Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L. Current medical research and opinion 38 (9) (2022)
Karen L Reckamp, Huamao Mark Lin, Holly L Cranmer, Yanyu Wu, Pingkuan Zhang, Laura J Walton, Stephen Kay, Allie Cichewicz, Binod Neupane, Kyle Fahrbach, Sanjay Popat, D Ross Camidge
Indirect comparisons of brigatinib and alectinib for front-line ALK -positive non-small-cell lung cancer. Future oncology (London, England) 18 (20) (2022)
Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, Hyun Ae Jung, Jin-Yuan Shih, Cheol Kyu Park, Seung Hyeun Lee, Tatsuro Okamoto, Hee Kyung Ahn, Yong Chul Lee, Yuki Sato, Sung Sook Lee, Celine Mascaux, Hasan Daoud, Angela Märten, Satoru Miura
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG). The oncologist 27 (4) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Sanjay Popat, Stephen V Liu, Nicolas Scheuer, Grace G Hsu, Alexandre Lockhart, Sreeram V Ramagopalan, Frank Griesinger, Vivek Subbiah
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer. Nature communications 13 (1) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Maria Rosario Garcia Campelo, Caicun Zhou, Suresh S Ramalingam, Huamao M Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Erin Goodman, Minal Mehta, Sanjay Popat, Pasi A Jänne
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort. Journal of clinical medicine 12 (1) (2022)
Colin R Lindsay, Emily C Shaw, David A Moore, Doris Rassl, Mariam Jamal-Hanjani, Nicola Steele, Salma Naheed, Craig Dick, Fiona Taylor, Helen Adderley, Fiona Black, Yvonne Summers, Matt Evans, Alexandra Rice, Aurelie Fabre, William A Wallace, Siobhan Nicholson, Alex Haragan, Phillipe Taniere, Andrew G Nicholson, Gavin Laing, Judith Cave, Martin D Forster, Fiona Blackhall, John Gosney, Sanjay Popat, Keith M Kerr
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists. British journal of cancer 125 (9) (2021)
Wanyuan Cui, Sanjay Popat
Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma. Drugs 81 (9) (2021)
Sanjay Popat, Geoffrey Liu, Shun Lu, Gregory Song, Xin Ma, James Chih-Hsin Yang
Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3). Future oncology (London, England) 17 (32) (2021)
Gary M Middleton, Peter Fletcher, Sanjay Popat, Joshua S Savage, Yvonne Summers, Alastair Greystoke, David Gilligan, Judith Cave, Noelle O'Rourke, Alison Brewster, Elizabeth Toy, James Spicer, Pooja Jain, Adam Dangoor, Melanie Mackean, Martin Forster, Amanda Farley, Dee Wherton, Manita Mehmi, Rowena Sharpe, Tara C Mills, Maria Antonietta Cerone, Timothy Anthony Yap, Thomas B K Watkins, Emilia Lim, Charles Swanton, Lucinda Billingham
The National Lung Matrix Trial of personalized therapy in lung cancer. Nature 583 (7818) (2020)
Sanjay Popat, Neal Navani, Keith M Kerr, Egbert F Smit, Timothy J P Batchelor, Paul Van Schil, Suresh Senan, Fiona McDonald
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach. The oncologist 26 (2) (2020)
Nadza Tokaca, Wanyuan Cui, Stephen Hazell, Andrew G Nicholson, Nicholas Van As, Sanjay Popat
Squamous Non-Small-Cell Lung Cancer Molecularly Reclassified as Transdifferentiated Prostate Cancer Due to Identification of TMPRSS2-ERG Translocation With SOX2 Amplification. JCO oncology practice 16 (10) (2020)
Sanjay Popat
Hyperprogression with immunotherapy: Is it real? Cancer 125 (8) (2019)

Sanjay Popat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sanjay Popat